Jia Zhou

Jia Zhou

Auto-generated profile, based on publicly available information

Jia Zhou

College of Chinese Materia Medica, Jilin Agricultural University, Changchun, Jilin Province, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2017 in BIO Web of Conferences
Verified
Journal Article
Open access
MZMing Zhang
Ming Zhang
SLShengfu Lu
Shengfu Lu
MLMi Li
Mi Li
QZQian Zhai
Qian Zhai
JZJia Zhou
Jia Zhou
NZNing Zhong
Ning Zhong

22 November 2018 in Journal of Algebra and Its Applications
Verified
Journal Article
Closed access
JZJia Zhou
Jia Zhou
LCLiangyun Chen
Liangyun Chen
YMYao Ma
Yao Ma
BSBing Sun
Bing Sun

3 September 2025 in Regenerative Medicine Reports
Verified
Journal Article
Open access
TZTingting Zhang
Tingting Zhang
XDXiaowei Dai
Xiaowei Dai
AMAkmal Muhammad
Akmal Muhammad
ZHZhongmei He
Zhongmei He
RDRui Du
Rui Du
JZJia Zhou
Jia Zhou
JOURNAL/rmrep/04.03/02273995-202601000-00003/figure1/v/2026-04-20T130259Z/r/image-tiff Objectives: Currently, treatment options for alcohol-induced liver disease and drug-induced liver injury are limited, especially in terms of effectiveness in repairing acute liver injury and severe fibrosis stages. Despite the known anti-inflammatory, antioxidant, and hepatoprotective effects of traditional Chinese medicine Sanghuang , the exact mechanisms by which its active components facilitate liver injury repair and regeneration remain unclear. The study investigated the pharmacological effects of Sanghuang in mitigating liver injury and promoting liver regeneration using network pharmacology and molecular docking technology. Methods: Active components of Sanghuang and their potential targets were retrieved from HERB and PubChem databases. Liver injury-related genes were collected from Disgenet and GeneCards. The intersecting targets were analyzed to construct compound-target and protein–protein interaction networks. Core targets were identified, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed. Molecular docking was conducted to validate the binding affinity between key components and core targets. Results: A total of 127 compound-related targets and 9856 liver injury-related targets were identified, with 120 intersecting genes. Protein–protein interaction network analysis identified 14 core targets, including ESR1, PTGS2, EGFR, MMP9, PGR, STAT3, BCL2L1, AR, NFE2L2, HIF1A, ERBB2, MAPK1, ALB, and TLR4. Enrichment analysis suggested these targets are involved in pathways such as HIF-1 signaling and Pathways in cancer. Molecular docking demonstrated strong binding affinities between specific Sanghuang components (e.g., ursolic acid, eburicoic acid) and core targets, with binding energies as low as –10.8 kcal/mol. Conclusion: This integrated analysis predicts that Sanghuang may ameliorate liver injury and promote regeneration by multi-target modulation of key pathways, including HIF-1α and MAPK signaling. The findings provide a theoretical foundation for the potential application of Sanghuang in regenerative medicine for liver diseases and warrant further experimental validation.

17 November 2026 in Neural Regeneration Research
Verified
Journal Article
Open access
HMHaoxin Ma
Haoxin Ma
DCDeyan Chen
Deyan Chen
SLShiying Liu
Shiying Liu
WSWenyue Sun
Wenyue Sun
DSDiwen Sun
Diwen Sun
KFKaijian Fan
Kaijian Fan
This review aims to summarize recent progress in brain organoid technology for research into neural regeneration, focusing on its theoretical foundations, technical development, translational challenges, and future directions. Brain organoids are three-dimensional biomimetic in vitro models that capture some key features of neural development and pathology. They provide platforms for investigating brain tissue organization and the molecular and cellular processes underlying neural regeneration. Their potential applications include studying disease mechanisms and brain injury, testing neurotoxicity, and screening drugs for neurological disorders. Organoids may also inform research on tissue repair and transplantation, although their clinical applications remain under investigation. This review examines current approaches to generating and improving brain organoids, as well as the technical, ethical, and regulatory issues that may affect their use and translation. Key limitations include incomplete maturation and vascularization, the absence of important immune components, and variation between models arising from limited standardization. Future research could explore guided culture and assembly, high-throughput screening, and bioprinting to improve model performance. Multi-omics approaches may also help characterize organoids and support efforts to strengthen standardization. In addition, combining organoid platforms with gene-editing techniques may offer further opportunities for studying disease mechanisms. This review identifies research priorities and discusses how more accurate models, rigorous quality control, and appropriate oversight may support the further development of brain organoids for neural regeneration research.